EBA
BIO icon

Eagle Bay Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Eagle Bay Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$14.4K – 852
2023
Q1 		$14.4K Hold
30
– – 0.01% 558
2022
Q4 		$12.6K Hold
30
– – 0.01% 584
2022
Q3 		$13K Hold
30
– – 0.01% 563
2022
Q2 		$14.8K Buy
+30
New +$15.6K 0.01% 594
2022
Q1 		– Sell
-30
Closed -$23K – 372
2021
Q4 		$23K Hold
30
– – 0.02% 532
2021
Q3 		$22K Hold
30
– – 0.01% 597
2021
Q2 		$20K Buy
+30
New +$18.3K 0.02% 544

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return